US Stock MarketDetailed Quotes
FBRX Forte Biosciences
- 16.000
- +0.360+2.30%
Close Nov 22 16:00 ET
- 15.760
- -0.240-1.50%
Post 20:01 ET
23.39MMarket Cap-976P/E (TTM)
16.670High14.040Low396.66KVolume15.210Open15.640Pre Close6.20MTurnover43.17%Turnover RatioLossP/E (Static)1.46MShares21.25052wk High2.50P/B14.70MFloat Cap4.11052wk Low--Dividend TTM918.91KShs Float6732.375Historical High--Div YieldTTM16.82%Amplitude4.110Historical Low15.630Avg Price1Lot Size
About Forte Biosciences Company
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Company Profile
SymbolFBRX
Company NameForte Biosciences
Listing DateApr 13, 2017
Issue Price10.00
Founded2017
CEODr. Paul A. Wagner, PhD
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address3060 Pegasus Park Drive,Building 6
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75247
Phone1-310-618-6994
Websitehttp://www.fortebiorx.com
Company Executives
- Name
- Position
- Salary
- Dr. Paul A. Wagner, PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.45M
- Antony A. Riley
- Chief Financial Officer
- 722.98K
- Dr. Barbara K. Finck, M.D.
- Director
- 61.73K
- Steven Kornfeld
- Independent Director
- 97.73K
- Donald A. Williams
- Independent Director
- 85.73K
- David W. Gryska, M.B.A.
- Independent Director
- 104.30K
- Dr. Lawrence Eichenfield, M.D.
- Independent Director
- 62.73K
- Dr. Stephen K. Doberstein, PhD
- Independent Director
- 62.73K
- Dr. Scott C. Brun, M.D.
- Independent Director
- 62.73K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data